U.S. Medical Equipment Stock News

NasdaqGS:BIDU
NasdaqGS:BIDUInteractive Media and Services

Baidu (NasdaqGS:BIDU) One Off Loss Drives 0.3% Margin And Tests Earnings Rebuild Narrative

Baidu (NasdaqGS:BIDU) opened Q1 2026 with revenue of C¥32.1b and basic EPS of C¥10.13, compared with C¥34.1b of revenue and basic EPS of C¥13.27 in Q4 2024. On a trailing 12 month basis, EPS stood at C¥1.15. Over recent quarters the company has seen revenue move from C¥32.5b and EPS of C¥22.44 in Q1 2025, through a loss-making Q3 2025, before settling at revenue of C¥32.1b and EPS of C¥10.13 this quarter. This sets up an earnings story where a 0.3% trailing net margin and a large one-off loss...
NasdaqGS:ADUS
NasdaqGS:ADUSHealthcare

Addus HomeCare Pursues Personal Care M&A As Shares Trade Below Targets

Addus HomeCare is leaning into its acquisition playbook in personal care services, with management signaling interest in larger deals supported by a solid balance sheet. The company reports that recent federal moratoriums on certain home health licenses have had limited impact, since its core growth focus is personal care, which is outside the new restrictions. Operations in Illinois, Texas, and New Mexico are showing improving personal care service trends, aided by technology investments...
NasdaqGS:IONS
NasdaqGS:IONSBiotechs

Ionis Rises As Diranersen Phase 2 Spurs Biogen Registrational Plans

Biogen and Ionis reported topline Phase 2 CELIA data for diranersen in early Alzheimer's disease, showing robust biomarker and cognitive effects. The antisense therapy targets tau, and the trial offers the first randomized Phase 2 evidence that this approach can pair biomarker reductions with clinical benefit. Biogen plans to move diranersen into registrational studies, positioning Ionis's tau program for potential late stage development. For investors tracking Ionis Pharmaceuticals...
NasdaqGS:VIAV
NasdaqGS:VIAVCommunications

Is It Too Late To Consider Viavi Solutions (VIAV) After Its Surging Share Price?

Investors may be wondering whether Viavi Solutions at US$49.28 is still priced attractively after a big run, or if the easy money has already been made. The stock has pulled back about 7.7% over the last week. However, it is up 11.7% over the last month, 171.5% year to date and 432.2% over the past year. Recent coverage has focused on Viavi Solutions as a high momentum tech stock, with investors reacting to its strong share price move over the last 12 months. Commentary has also highlighted...
NYSE:MMI
NYSE:MMIReal Estate

Marcus And Millichap Spotlights STNL Retail Strength And New Leadership

Marcus & Millichap (NYSE:MMI) has released new national research reports on the U.S. single tenant net lease retail sector. The reports highlight strength in STNL retail fundamentals and a pickup in transaction activity. The findings focus on financing conditions and market activity within a key business line for the company. For investors following Marcus & Millichap, the new STNL research adds another piece to the picture around the company’s retail-focused brokerage and advisory work...
NasdaqGS:WSBC
NasdaqGS:WSBCBanks

How Investors Are Reacting To WesBanco (WSBC) Pushing Into Higher-Growth Markets Amid CRE And Cost Risks

In recent months WesBanco has completed the integration of Premier Financial and continued its push into higher-growth markets such as Northern Virginia and Knoxville, reshaping its regional footprint. This expansion is reshaping the bank’s mix of loans and deposits, with investors closely watching how it balances growth opportunities against commercial real estate and cost risks. Next, we’ll examine how WesBanco’s expansion into markets like Northern Virginia and Knoxville may influence...
NYSE:AME
NYSE:AMEElectrical

AMETEK Board Change And Indicor Talks Spark Fresh Valuation Questions

AMETEK (NYSE:AME) has appointed former Hexcel CEO Nick L. Stanage to its Board of Directors. The company is in discussions to acquire a portfolio of instrumentation businesses from Indicor, LLC. Both developments relate to AMETEK's focus on expanding its presence in advanced instrumentation and industrial technology markets. AMETEK operates as a global manufacturer of electronic instruments and electromechanical devices, serving industrial and aerospace customers, among others. The...
NasdaqGM:GCT
NasdaqGM:GCTRetail Distributors

Why GigaCloud Technology (GCT) Is Down 6.3% After Q1 Beat, Buybacks And Revenue Guidance Update

Earlier in May 2026, GigaCloud Technology Inc. reported first-quarter 2026 results showing revenue of US$359.49 million and net income of US$38.12 million, issued second-quarter revenue guidance of US$365 million to US$390 million, completed a US$42.6 million share repurchase program, and outlined its outlook ahead of a conference appearance in New York. The results highlighted continued expansion of GigaCloud’s global B2B marketplace, including strong third-party seller activity and...
NasdaqGS:ATLC
NasdaqGS:ATLCConsumer Finance

Wellington Stake Puts Focus On Atlanticus Earnings Momentum And Risks

Wellington Management affiliates have disclosed a new passive 5.06% stake in Atlanticus Holdings (NasdaqGS:ATLC) via a Schedule 13G filing. The filing signals fresh institutional attention on the company’s credit focused business model. The new position has not been covered in recent commentary on Atlanticus and is separate from earnings or valuation discussions. Atlanticus Holdings, trading at $78.1, has drawn renewed interest after the Wellington position. The stock has shown a 53.9%...
NasdaqCM:GOAI
NasdaqCM:GOAIMedia

Fastest Growing AdTech Companies to Watch in 2026

Bailey Pemberton
Advertising technology has become one of the most interesting corners of the market. As businesses continue shifting budgets toward digital channels, advertisers are looking for tools that can improve return on ad spend, automate campaign decisions, and turn marketing dollars into measurable results.
NasdaqGS:EWTX
NasdaqGS:EWTXPharmaceuticals

Assessing Edgewise Therapeutics (EWTX) Valuation After Strong Multi Year Shareholder Returns

Recent share performance and business context Edgewise Therapeutics (EWTX) has drawn investor attention after a mixed stretch in the stock, with the price down about 9% over the past month but up roughly 4% over the past 3 months. Over longer periods, the stock shows a year to date gain of about 32% and a 1 year total return a little above 111%, alongside a 3 year total return a little above 224%, on a market value near US$3.4b. The company focuses on therapies for muscle disorders, with lead...
NYSE:ADC
NYSE:ADCRetail REITs

Should Agree Realty’s (ADC) Dividend Hike and Insider Buying Shift How Investors View Its Income Strategy?

Agree Realty Corporation recently declared a monthly cash dividend of US$0.267 per common share and US$0.08854 per Series A preferred depositary share, with payments scheduled in early June 2026 to shareholders of record in late May. This common dividend represents a 4.3% annualized increase from the prior level and comes alongside stronger-than-expected first-quarter 2026 results and increased insider share purchases by the CEO and several directors, highlighting management’s commitment to...
NasdaqGS:CCC
NasdaqGS:CCCSoftware

Is CCC Intelligent Solutions Holdings (CCC) Now Attractive After Sharp Share Price Declines?

Wondering whether CCC Intelligent Solutions Holdings at US$4.61 is starting to look cheap or still carries more risk than reward? This article focuses squarely on what the current share price might reflect. The stock has risen 2.0% over the past week, but is still down 18.3% over the last 30 days and has fallen 41.4% year to date, with a 50.1% decline over the past year and a 53.9% decline over the past three and five years. Recent attention around CCC Intelligent Solutions Holdings has...
NasdaqCM:VUZI
NasdaqCM:VUZIElectronic

Is Vuzix (VUZI) Trading Near-Term Losses for a Leaner Long-Term Cost Structure?

In May 2026, Vuzix Corporation reported first-quarter results showing revenue of US$1.39 million, down from US$1.58 million a year earlier, alongside a net loss of US$7.07 million versus US$8.64 million previously. Although sales slipped, the reduced net loss and narrower basic loss per share suggest some progress in managing costs and operating efficiency. With first-quarter results showing lower revenue but a smaller net loss, we’ll examine how this update shapes Vuzix’s investment...
NasdaqGS:EXC
NasdaqGS:EXCElectric Utilities

Will Exelon's (EXC) Revenue Gain and Reaffirmed Targets Reset Its Long-Term Earnings Narrative?

In the past quarter ended March 31, 2026, Exelon Corporation reported Q1 revenue of US$7,242 million, up from US$6,714 million a year earlier, with net income of US$919 million and basic and diluted earnings per share from continuing operations steady at US$0.90. Although earnings per share were flat year over year, Exelon’s ability to lift revenue while reaffirming its longer-term operating earnings growth targets underscores management’s confidence in the current capital investment and...
NYSE:BMI
NYSE:BMIElectronic

A Look At Badger Meter (BMI) Valuation After Securities Fraud Investigation And Weaker Q1 2026 Sales

Badger Meter (BMI) is back in focus after a securities fraud investigation was launched, following its disclosure of lower first quarter 2026 sales and allegations regarding statements on product demand and growth prospects. See our latest analysis for Badger Meter. Badger Meter's share price has been volatile around the fraud probe and weaker first quarter 2026 sales, with a 7 day share price return of 3.58% but a year to date share price return down 32.45%. The 5 year total shareholder...
NYSE:SPHR
NYSE:SPHREntertainment

A Look At Sphere Entertainment (SPHR) Valuation After Abu Dhabi Sphere Expansion On Yas Island

Sphere Entertainment (SPHR) is back in focus after Abu Dhabi selected Yas Island as the site for Sphere Abu Dhabi, a US$1.7b immersive venue that marks the company’s first international expansion. See our latest analysis for Sphere Entertainment. At a share price of US$135.33, the stock has eased slightly over the past day and month, yet a 17.43% 90 day share price return and very large 1 year total shareholder return suggest momentum has been building rather than fading. If Sphere’s...
NYSE:SGHC
NYSE:SGHCHospitality

A Look At Super Group (SGHC) Valuation After Reaffirmed 2026 Revenue Guidance And Strong Q1 Results

Super Group (SGHC) (SGHC) is back in focus after first quarter 2026 results, reaffirmed full year revenue guidance of at least US$2.55b, and fresh filings that update how the business is reported geographically. See our latest analysis for Super Group (SGHC). The reaffirmed 2026 revenue guidance, Q1 earnings update, insider filings and a series of investor conferences have come alongside strong momentum, with a 30 day share price return of 22.85% and a 1 year total shareholder return of...
NasdaqGM:BLBD
NasdaqGM:BLBDMachinery

Blue Bird Pension Transfer Reshapes Liabilities And Investor Considerations

Blue Bird Corporation (NasdaqGM:BLBD) has fully terminated its frozen defined benefit pension plan. The company settled US$94 million of pension liabilities through a pension risk transfer to Pacific Life. The transfer shifts obligations for more than 2,000 participants from Blue Bird to Pacific Life and results in a non-cash settlement charge for the company. Blue Bird, a long-standing manufacturer in the school bus industry, operates in a segment that attracts attention from investors...
NasdaqGS:LFST
NasdaqGS:LFSTHealthcare

The Bull Case For LifeStance Health Group (LFST) Could Change Following Revived Tuck-In M&A And Higher 2026 Guidance - Learn Why

Earlier in May 2026, LifeStance Health Group reported first-quarter revenue of US$403.48 million, a rise from US$332.97 million a year earlier, with net income improving to US$14.24 million and full-year 2026 revenue guidance lifted to US$1.64 billion–US$1.68 billion alongside new tuck-in acquisitions and a completed US$285.25 million follow-on equity offering. An interesting angle is that management is reactivating tuck-in M&A after a three-year pause, using smaller acquisitions to open new...
NYSE:AN
NYSE:ANSpecialty Retail

Is It Time To Revisit AutoNation (AN) After The Recent Share Price Pullback?

For investors wondering whether AutoNation at around US$178.59 is offering value or just headline noise, this article walks through what the current share price really implies. The stock has pulled back recently, with returns down 8.6% over the past week, down 14.1% over the last 30 days, and down 13.5% year to date, even though the 3-year and 5-year returns stand at 30.4% and 78.7% respectively. Recent attention on AutoNation has focused on how the stock has traded after these pullbacks and...
NasdaqCM:ATEX
NasdaqCM:ATEXTelecom

FCC Satellite Trials Put Focus On Anterix Valuation And Momentum

FCC approves experimental trials by Anterix and Lynk Global for satellite direct to device communications using licensed 900 MHz spectrum. Trials aim to support secure, resilient connectivity for critical infrastructure sectors, including utilities, logistics, and transportation. The FCC decision positions Anterix to test integrated satellite and terrestrial wireless offerings alongside its existing private wireless focus. For investors watching NasdaqCM:ATEX, this FCC approval comes with...
NYSE:BWA
NYSE:BWAAuto Components

BorgWarner Euro 7 Win Extends Heavy Duty Diesel And EV Story

BorgWarner (NYSE:BWA) has secured a major supply contract for a Euro 7-compliant heavy-duty commercial vehicle platform in Europe. The company will provide VTG turbochargers and EGR coolers for a leading European OEM's 6-cylinder heavy-duty diesel engine. The award deepens BorgWarner's role in on-highway commercial vehicles while aligning with tightening European emissions requirements. BorgWarner, known for its propulsion and emissions technologies for combustion, hybrid, and electric...
NYSE:NSC
NYSE:NSCTransportation

Is Norfolk Southern (NSC) Pricing In Too Much Optimism After Safety Scrutiny And Strong Gains?

If you are wondering whether Norfolk Southern at US$318.20 is priced for opportunity or already reflecting high expectations, the starting point is to look closely at what the market is paying for its fundamentals. The stock has returned 1.9% over the last 7 days, 5.2% over 30 days, 10.6% year to date and 32.8% over 1 year, with a 58.7% return over 3 years and 27.2% over 5 years, which gives useful context before comparing price to underlying value. Recent headlines around Norfolk Southern...